ARS Pharmaceuticals Inc (NASDAQ: SPRY) is 21.33% higher on its value in year-to-date trading and has touched a low of $6.29 and a high of $18.51 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SPRY stock was last observed hovering at around $12.75 in the last trading session, with the day’s gains setting it 0.05%.
Currently trading at $12.80, the stock is -0.92% and 1.73% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.85 million and changing 0.39% at the moment leaves the stock 7.53% off its SMA200. SPRY registered 100.94% gain for a year compared to 6-month gain of 30.88%. The firm has a 50-day simple moving average (SMA 50) of $12.5935 and a 200-day simple moving average (SMA200) of $11.881475.
The stock witnessed a 15.52% loss in the last 1 month and extending the period to 3 months gives it a -15.79%, and is -10.43% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.88% over the week and 7.22% over the month.
ARS Pharmaceuticals Inc (SPRY) has around 26 employees, a market worth around $1.24B and $2.57M in sales. Profit margin for the company is -1912.15%. Distance from 52-week low is 103.50% and -30.85% from its 52-week high. The company has generated returns on investments over the last 12 months (-24.43%).
The EPS is expected to grow by 2.82% this year
213.0 institutions hold shares in ARS Pharmaceuticals Inc (SPRY), with institutional investors hold 89.62% of the company’s shares. The shares outstanding are 97.15M, and float is at 51.12M with Short Float at 28.97%. Institutions hold 68.83% of the Float.
The top institutional shareholder in the company is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) with over 11.08 million shares valued at $94.27 million. The investor’s holdings represent 11.4409 of the SPRY Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 10.86 million shares valued at $92.43 million to account for 11.2168 of the shares outstanding. The other top investors are ORBIMED ADVISORS LLC which holds 9.24 million shares representing 9.5436 and valued at over $78.64 million, while BLACKROCK INC. holds 4.2182 of the shares totaling 4.08 million with a market value of $34.76 million.
ARS Pharmaceuticals Inc (SPRY) Insider Activity
The most recent transaction is an insider sale by Shawver Laura, the company’s Director. SEC filings show that Shawver Laura sold 50,000 shares of the company’s common stock on Feb 03 ’25 at a price of $12.31 per share for a total of $0.62 million. Following the sale, the insider now owns 0.21 million shares.
Still, SEC filings show that on Jan 06 ’25, Shawver Laura (Director) disposed off 50,000 shares at an average price of $11.10 for $0.56 million. The insider now directly holds 210,346 shares of ARS Pharmaceuticals Inc (SPRY).
